Acceleron
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics. Acceleron went public in September 2013 (NASDAQ: XLRN) and was then acquired by Merck (NYSE: MRK) in 2021.
Acceleron is a business in biotech based in United States, founded in 2003.
Within the biotech space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in United States.
The company is listed at the NASDAQ: XLRN / ACQUIRED BY: MERCK | Bessemer portfolio company stage of development.
| Sector | Biotech |
|---|---|
| Country | United States |
| Founded | 2003 |
| Stage | NASDAQ: XLRN / ACQUIRED BY: MERCK | Bessemer portfolio company |
Website: www.acceleronpharma.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account